Загрузка...
Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
Eluxadoline is a novel drug approved for the management of diarrhea predominant irritable bowel syndrome (IBS-D). It has unique pharmacology and works on three different opioid receptors. Several Phase II and III clinical trials have demonstrated eluxadoline’s efficacy in reducing symptoms related t...
Сохранить в:
| Опубликовано в: : | Drug Des Devel Ther |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5628681/ https://ncbi.nlm.nih.gov/pubmed/29033544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S127405 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|